Niagen Bioscience to Present at the 17th Annual Midwest IDEAS Investor Conference

Niagen Bioscience to Present at the 17th Annual Midwest IDEAS Investor Conference

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that senior management will present at the Midwest IDEAS Investor Conference on Thursday, August 27, 2026,at The InterContinental Chicago in Chicago, IL.

IDEAS Conferences offer independent regional venues for top-tier companies to present their investment merits to instrumental audiences of investment professionals, offering investor-sponsored events created to benefit regional investment communities.

Niagen Bioscience CFO, Ozan Pamir, will present on Thursday, August 27, from 2:40 - 3:15 PM CT in Presenting Room 2and be available for one-on-one meetings with institutional investors at the conference. The presentation will be livestreamed and can be accessed through the conference host’s main website: www.threepartadvisors.com/midwest.

If you would like to schedule a one-on-one meeting with the Niagen Bioscience management team during the conference, please contact your respective conference representative or email Niagen@KCSA.com.